1. Home
  2. UBX

UBX

Unity Biotechnology Inc.

Logo Unity Biotechnology Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Founded: 2009 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 26.4M IPO Year: 2018
Target Price: $8.67 AVG Volume (30 days): 91.0K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.20 EPS Growth: N/A
52 Week Low/High: $1.50 - $3.82 Next Earning Date: 05-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: